Skip to main content
Top
Published in: World Journal of Surgery 7/2013

01-07-2013

Clinical Implication of Cancer Adhesion in Papillary Thyroid Carcinoma: Clinicopathologic Characteristics and Prognosis Analyzed with Degree of Extrathyroidal Extension

Authors: Seung Pil Jung, Minkuk Kim, Jun-Ho Choe, Jee Soo Kim, Seok Jin Nam, Jung-Han Kim

Published in: World Journal of Surgery | Issue 7/2013

Login to get access

Abstract

Background

Macroscopic extrathyroidal extension (ETE) is a poor prognostic factor in papillary thyroid carcinoma (PTC). However, intraoperative inspection for ETE is often inaccurate and could lead the surgeon to misconstrue simple adhesion as gross ETE. Such confusion could result in more aggressive treatment than necessary. In the present study we investigated the frequency and clinical implication of simple adhesions.

Methods

We identified 858 patients who underwent total thyroidectomy for papillary thyroid carcinoma (PTC). Clinicopathologic features, prognosis, and stimulated serum thyroglobulin (Tg) levels were compared between four groups divided according to degree of ETE: no ETE (n = 335), simple adhesion (n = 16), microscopic ETE (n = 378), and macroscopic ETE (n = 129).

Results

In the total of 145 cases, which were recognized as gross ETE under intraoperative inspection, 16 cases (11.0 %) were diagnosed as cancer confined to the thyroid without ETE by definite histology. The simple adhesion group showed no statistical differences in postoperative stimulated Tg levels from the no ETE and microscopic ETE groups (p > 0.05). In contrast, the distribution of postoperative Tg levels in the macroscopic ETE group was significantly higher than in the other groups (p < 0.001). During the 54-month median follow-up period, the macroscopic ETE and microscopic ETE groups showed poorer relapse-free survival than the no ETE and simple adhesion groups (p < 0.05).

Conclusions

The findings of the present study indicate that the discrepancy between intraoperative inspection and definite histology is not negligible when dense adhesions are present. When no tumor is found, the patient with inflammatory or fibrotic adhesions has a favorable prognosis.
Literature
1.
go back to reference Schlumberger MJ (1999) Diagnostic follow-up of well-differentiated thyroid carcinoma: historical perspective and current status. J Endocrinol Invest 22:3–7PubMed Schlumberger MJ (1999) Diagnostic follow-up of well-differentiated thyroid carcinoma: historical perspective and current status. J Endocrinol Invest 22:3–7PubMed
2.
go back to reference Dean DS, Hay ID (2000) Prognostic indicators in differentiated thyroid carcinoma. Cancer Control 7:229–239PubMed Dean DS, Hay ID (2000) Prognostic indicators in differentiated thyroid carcinoma. Cancer Control 7:229–239PubMed
3.
go back to reference Cady B, Rossi R (1988) An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 104:947–953PubMed Cady B, Rossi R (1988) An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 104:947–953PubMed
4.
go back to reference DeGroot LJ, Kaplan EL, McCormick M et al (1990) Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 71:414–424PubMedCrossRef DeGroot LJ, Kaplan EL, McCormick M et al (1990) Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 71:414–424PubMedCrossRef
5.
go back to reference Hay ID (1990) Papillary thyroid carcinoma. Endocrinol Metab Clin North Am 19:545–576PubMed Hay ID (1990) Papillary thyroid carcinoma. Endocrinol Metab Clin North Am 19:545–576PubMed
6.
go back to reference Lin JD, Liou MJ, Chao TC et al (1999) Prognostic variables of papillary and follicular thyroid carcinoma patients with lymph node metastases and without distant metastases. Endocr Relat Cancer 6:109–115PubMedCrossRef Lin JD, Liou MJ, Chao TC et al (1999) Prognostic variables of papillary and follicular thyroid carcinoma patients with lymph node metastases and without distant metastases. Endocr Relat Cancer 6:109–115PubMedCrossRef
7.
go back to reference Andersen PE, Kinsella J, Loree TR et al (1995) Differentiated carcinoma of the thyroid with extrathyroidal extension. Am J Surg 170:467–470PubMedCrossRef Andersen PE, Kinsella J, Loree TR et al (1995) Differentiated carcinoma of the thyroid with extrathyroidal extension. Am J Surg 170:467–470PubMedCrossRef
8.
go back to reference Ortiz S, Rodriguez JM, Soria T et al (2001) Extrathyroid spread in papillary carcinoma of the thyroid: clinicopathological and prognostic study. Otolaryngol Head Neck Surg 124:261–265PubMedCrossRef Ortiz S, Rodriguez JM, Soria T et al (2001) Extrathyroid spread in papillary carcinoma of the thyroid: clinicopathological and prognostic study. Otolaryngol Head Neck Surg 124:261–265PubMedCrossRef
9.
go back to reference Edge SB, Compton CC (2010) The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 17:1471–1474PubMedCrossRef Edge SB, Compton CC (2010) The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 17:1471–1474PubMedCrossRef
10.
go back to reference Arora N, Turbendian HK, Scognamiglio T et al (2008) Extrathyroidal extension is not all equal: implications of macroscopic versus microscopic extent in papillary thyroid carcinoma. Surgery 144:942–947 discussion 947–948PubMedCrossRef Arora N, Turbendian HK, Scognamiglio T et al (2008) Extrathyroidal extension is not all equal: implications of macroscopic versus microscopic extent in papillary thyroid carcinoma. Surgery 144:942–947 discussion 947–948PubMedCrossRef
11.
go back to reference Hu A, Clark J, Payne RJ et al (2007) Extrathyroidal extension in well-differentiated thyroid cancer: macroscopic vs microscopic as a predictor of outcome. Arch Otolaryngol Head Neck Surg 133:644–649PubMedCrossRef Hu A, Clark J, Payne RJ et al (2007) Extrathyroidal extension in well-differentiated thyroid cancer: macroscopic vs microscopic as a predictor of outcome. Arch Otolaryngol Head Neck Surg 133:644–649PubMedCrossRef
12.
go back to reference Rivera M, Ricarte-Filho J, Tuttle RM et al (2010) Molecular, morphologic, and outcome analysis of thyroid carcinomas according to degree of extrathyroid extension. Thyroid 20:1085–1093PubMedCrossRef Rivera M, Ricarte-Filho J, Tuttle RM et al (2010) Molecular, morphologic, and outcome analysis of thyroid carcinomas according to degree of extrathyroid extension. Thyroid 20:1085–1093PubMedCrossRef
13.
14.
go back to reference Lopez MJ, Monafo WW (1993) Role of extended resection in the initial treatment of locally advanced colorectal carcinoma. Surgery 113:365–372PubMed Lopez MJ, Monafo WW (1993) Role of extended resection in the initial treatment of locally advanced colorectal carcinoma. Surgery 113:365–372PubMed
15.
go back to reference Ito Y, Tomoda C, Uruno T et al (2006) Prognostic significance of extrathyroid extension of papillary thyroid carcinoma: massive but not minimal extension affects the relapse-free survival. World J Surg 30:780–786. doi:10.1007/s00268-005-0270-z PubMedCrossRef Ito Y, Tomoda C, Uruno T et al (2006) Prognostic significance of extrathyroid extension of papillary thyroid carcinoma: massive but not minimal extension affects the relapse-free survival. World J Surg 30:780–786. doi:10.​1007/​s00268-005-0270-z PubMedCrossRef
16.
go back to reference Moon HJ, Kim E-K, Chung WY et al (2011) Minimal extrathyroidal extension in patients with papillary thyroid microcarcinoma: is it a real prognostic factor? Ann Surg Oncol 18:1916–1923PubMedCrossRef Moon HJ, Kim E-K, Chung WY et al (2011) Minimal extrathyroidal extension in patients with papillary thyroid microcarcinoma: is it a real prognostic factor? Ann Surg Oncol 18:1916–1923PubMedCrossRef
17.
go back to reference Ersoz C, Soylu L, Erkocak EU et al (1997) Histologic alterations in the thyroid gland after fine-needle aspiration. Diagn Cytopathol 16:230–232PubMedCrossRef Ersoz C, Soylu L, Erkocak EU et al (1997) Histologic alterations in the thyroid gland after fine-needle aspiration. Diagn Cytopathol 16:230–232PubMedCrossRef
18.
go back to reference Polyzos SA, Patsiaoura K, Zachou K (2009) Histological alterations following thyroid fine needle biopsy: a systematic review. Diagn Cytopathol 37:455–465PubMedCrossRef Polyzos SA, Patsiaoura K, Zachou K (2009) Histological alterations following thyroid fine needle biopsy: a systematic review. Diagn Cytopathol 37:455–465PubMedCrossRef
19.
go back to reference Nikiforov Y (2012) Diagnostic pathology and molecular genetics of the thyroid, 2nd Edition. Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia, p. xi, 436 p Nikiforov Y (2012) Diagnostic pathology and molecular genetics of the thyroid, 2nd Edition. Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia, p. xi, 436 p
20.
go back to reference Pacini F, Lippi F, Formica N et al (1987) Therapeutic doses of iodine-131 reveal undiagnosed metastases in thyroid cancer patients with detectable serum thyroglobulin levels. J Nucl Med 28:1888–1891PubMed Pacini F, Lippi F, Formica N et al (1987) Therapeutic doses of iodine-131 reveal undiagnosed metastases in thyroid cancer patients with detectable serum thyroglobulin levels. J Nucl Med 28:1888–1891PubMed
21.
go back to reference Muratet JP, Giraud P, Daver A et al (1997) Predicting the efficacy of first iodine-131 treatment in differentiated thyroid carcinoma. J Nucl Med 38:1362–1368PubMed Muratet JP, Giraud P, Daver A et al (1997) Predicting the efficacy of first iodine-131 treatment in differentiated thyroid carcinoma. J Nucl Med 38:1362–1368PubMed
22.
go back to reference Menendez Torre E, Lopez Carballo MT, Rodriguez Erdozain RM et al (2004) Prognostic value of thyroglobulin serum levels and 131I whole-body scan after initial treatment of low-risk differentiated thyroid cancer. Thyroid 14:301–306PubMedCrossRef Menendez Torre E, Lopez Carballo MT, Rodriguez Erdozain RM et al (2004) Prognostic value of thyroglobulin serum levels and 131I whole-body scan after initial treatment of low-risk differentiated thyroid cancer. Thyroid 14:301–306PubMedCrossRef
23.
go back to reference Toubeau M, Touzery C, Arveux P et al (2004) Predictive value for disease progression of serum thyroglobulin levels measured in the postoperative period and after (131)I ablation therapy in patients with differentiated thyroid cancer. J Nucl Med 45:988–994PubMed Toubeau M, Touzery C, Arveux P et al (2004) Predictive value for disease progression of serum thyroglobulin levels measured in the postoperative period and after (131)I ablation therapy in patients with differentiated thyroid cancer. J Nucl Med 45:988–994PubMed
24.
go back to reference Hall FT, Beasley NJ, Eski SJ et al (2003) Predictive value of serum thyroglobulin after surgery for thyroid carcinoma. Laryngoscope 113:77–81PubMedCrossRef Hall FT, Beasley NJ, Eski SJ et al (2003) Predictive value of serum thyroglobulin after surgery for thyroid carcinoma. Laryngoscope 113:77–81PubMedCrossRef
25.
go back to reference Ruiz-Garcia J, Ruiz de Almodovar JM, Olea N et al (1991) Thyroglobulin level as a predictive factor of tumoral recurrence in differentiated thyroid cancer. J Nucl Med 32:395–398PubMed Ruiz-Garcia J, Ruiz de Almodovar JM, Olea N et al (1991) Thyroglobulin level as a predictive factor of tumoral recurrence in differentiated thyroid cancer. J Nucl Med 32:395–398PubMed
26.
go back to reference Spencer CA, Wang CC (1995) Thyroglobulin measurement. Techniques, clinical benefits, and pitfalls. Endocrinol Metab Clin North Am 24:841–863PubMed Spencer CA, Wang CC (1995) Thyroglobulin measurement. Techniques, clinical benefits, and pitfalls. Endocrinol Metab Clin North Am 24:841–863PubMed
27.
go back to reference Black EG, Hoffenberg R (1983) Should one measure serum thyroglobulin in the presence of anti-thyroglobulin antibodies? Clin Endocrinol (Oxf) 19:597–601CrossRef Black EG, Hoffenberg R (1983) Should one measure serum thyroglobulin in the presence of anti-thyroglobulin antibodies? Clin Endocrinol (Oxf) 19:597–601CrossRef
28.
go back to reference Vincze B, Sinkovics I, Keresztes S et al (2004) Clinical significance of serum thyroglobulin and antithyroglobulin antibody in differentiated thyroid cancer after thyroid ablation. Magy Onkol 48:27–34PubMed Vincze B, Sinkovics I, Keresztes S et al (2004) Clinical significance of serum thyroglobulin and antithyroglobulin antibody in differentiated thyroid cancer after thyroid ablation. Magy Onkol 48:27–34PubMed
29.
go back to reference Cooper DS, Doherty GM, Haugen BR et al (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167–1214PubMedCrossRef Cooper DS, Doherty GM, Haugen BR et al (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167–1214PubMedCrossRef
Metadata
Title
Clinical Implication of Cancer Adhesion in Papillary Thyroid Carcinoma: Clinicopathologic Characteristics and Prognosis Analyzed with Degree of Extrathyroidal Extension
Authors
Seung Pil Jung
Minkuk Kim
Jun-Ho Choe
Jee Soo Kim
Seok Jin Nam
Jung-Han Kim
Publication date
01-07-2013
Publisher
Springer-Verlag
Published in
World Journal of Surgery / Issue 7/2013
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-013-2034-5

Other articles of this Issue 7/2013

World Journal of Surgery 7/2013 Go to the issue